Peel Hunt assumed coverage on shares of Luceco (LON:LUCE) in a report published on Wednesday, ThisIsMoney.Co.Uk reports. The firm issued an add rating and a GBX 120 ($1.57) price objective on the stock.

Separately, Numis Securities reaffirmed a buy rating and issued a GBX 115 ($1.50) price objective on shares of Alliance Pharma in a research note on Friday, May 24th.

LON:LUCE opened at GBX 103.20 ($1.35) on Wednesday. The firm’s 50-day simple moving average is GBX 117.57. Luceco has a 52 week low of GBX 32.10 ($0.42) and a 52 week high of GBX 133 ($1.74). The company has a market capitalization of $165.95 million and a PE ratio of 114.67. The company has a current ratio of 1.29, a quick ratio of 0.72 and a debt-to-equity ratio of 88.35.

About Luceco

Luceco plc manufactures and distributes various light emitting diode (LED) lighting products and wiring accessories in the United Kingdom, Europe, the Middle East, the Americas, the Asia Pacific, and Africa. It operates through four segments: Wiring Accessories, Portable Power, LED Lighting, and Ross and Other.

Featured Article: Investing strategies using the yield curve

Receive News & Ratings for Luceco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luceco and related companies with MarketBeat.com's FREE daily email newsletter.